欧美亚洲国内精品bt,欧美激情精品久久久久久蜜臀,欧美a级免费黄片视频,久久一区二区三区精品

當(dāng)前位置:首頁  >  技術(shù)文章  >  EPHA3可能是一種新的預(yù)后生物標(biāo)志物并與膀胱癌免疫浸潤相關(guān)

EPHA3可能是一種新的預(yù)后生物標(biāo)志物并與膀胱癌免疫浸潤相關(guān)

更新時(shí)間:2024-12-28  |  點(diǎn)擊率:286

20231月,汕頭大學(xué)醫(yī)學(xué)院第二附屬醫(yī)院泌尿外科;廣州醫(yī)科大學(xué)第五附屬醫(yī)院泌尿外科;中山大學(xué)第一附屬醫(yī)院泌尿外科 (Department of Urology, The Second Affiliated Hospital of Shantou University, Medical College,Shantou 515041, ChinaDepartment of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510700, China;Department of Urology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China) Hao Lin老師研究團(tuán)隊(duì)在《Cancers》上發(fā)表論文:

EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer"

 

EPHA3可能是一種新的預(yù)后生物標(biāo)志物并與膀胱癌免疫浸潤相關(guān)"

 

Abstract

Purpose: To assess the mechanism of EPH receptor A3 (EPHA3) and its potential value for immunotherapy in BLCA.

Materials and methods: The Cancer Genome Atlas (TCGA) bladder cancer (BLCA) database and the Gene Expression Omnibus (GEO) database were used for assessing whether EHPA3 could be used to predict BLCA prognosis. This work carried out in vitro and in vivo assays for exploring how EPHA3 affected the biological behaviors. The downstream pathway was explored using a Western blotting technique. The CIBERSORT, ESTIMATE, TIMER, and TIDE tools were used to predict the immunotherapy value of EPHA3 in BLCA.

Results: EPHA3 was poorly expressed in BLCA (p < 0.05), its high expression is related to a good survival prognosis (p = 0.027 and p = 0.0275), and it has a good predictive ability for the histologic grade and status of BLCA (area under curve = 0.787 and 0.904). Overexpressed EPHA3 could inhibit BLCA cell biological behaviors, and it be associated with the downregulation of the Ras/pERK1/2 pathway. EPHA3 was correlated with several immune-infiltrating cells and the corresponding marker genes.

Conclusions: EPHA3 could be regarded as an acceptable anti-cancer biomarker in BLCA. EPHA3 plays an inhibiting role in BLCA, and it could be the candidate immunotherapeutic target for BLCA.


摘要:

目的:探討EPH受體A3 (EPHA3)的作用機(jī)制及其在BLCA免疫治療中的潛在價(jià)值。材料與方法:采用Cancer Genome Atlas (TCGA)膀胱癌(BLCA)數(shù)據(jù)庫和Gene Expression Omnibus (GEO)數(shù)據(jù)庫評估EHPA3是否可用于預(yù)測BLCA預(yù)后。本工作通過體外和體內(nèi)實(shí)驗(yàn)探討EPHA3對生物行為的影響。使用Western blotting技術(shù)探索下游途徑。采用CIBERSORT、ESTIMATETIMERTIDE工具預(yù)測EPHA3BLCA中的免疫治療價(jià)值。結(jié)果:EPHA3BLCA中表達(dá)較低(p < 0.05),其高表達(dá)與較好的生存預(yù)后相關(guān)(p = 0.027p = 0.0275),對BLCA的組織學(xué)分級和狀態(tài)有較好的預(yù)測能力(曲線下面積分別為0.7870.904)。EPHA3過表達(dá)可抑制BLCA細(xì)胞的生物學(xué)行為,并與Ras/pERK1/2通路下調(diào)有關(guān)。EPHA3與多種免疫浸潤細(xì)胞及相應(yīng)的標(biāo)記基因相關(guān)。結(jié)論:EPHA3可作為BLCA的一種可接受的抗癌生物標(biāo)志物。EPHA3BLCA中具有抑制作用,可能成為BLCA的候選免疫治療靶點(diǎn)。

 

該論文中,人類膀胱癌細(xì)胞(5637UMUC-3T24)以及正常的人類尿上皮細(xì)胞(SVHUC)的體外培養(yǎng)是使用Ausbian特級胎牛血清完成的。


美女亚洲福利视频| 开心五月播五月亚洲第一| 欧美老熟妇又粗又大| 国产一区二区三区免费观在线| 鸡巴操骚逼视频播放| 国产163黄网人看人人爽| 国产午夜福利视频第三区| 日韩一区二区三区国色天香| 鸡巴操美女小穴羞羞视频| 精品无码一区二区三区无码| 日韩精品欧美喷水| 大鸡巴日大鸡巴在线观看| 女人182毛片a级毛片| 熟妇好大好深好爽| 黑人大屌爆操骚货| 日本熟妇一区二区三区四区| 久久亚洲精品无码AV宋| 日韩有码视频在线| 西西大尺度无码免费视频| 野外日逼视频免费看| 帅哥大鸡巴操美女| 99久久久国产精品美女| 欧美精品性做久久久久久| 搬开女人下面使劲插视频| 日韩一区二区三区国色天香| 日韩欧美综合一二三区| 午夜福利在线观看aaa| 国产一区二区三区三级88| 五月天国产成人av在线| 久久久久久久久中文字幕| 国产三级精品久久久久| 最是人间烟火色在线播放| av黄色资源在线观看| 丝袜片一区二区三区四区五区| 久久久久黑人强伦姧人妻| 久久国产精品成人18p| 欧美日韩精品视频在线第一区| 久久精品国产自清天天线| 欧美黄色三级成人小视频| 大鸡巴日大鸡巴在线观看| 大鸡吧视频在线观看|